Sandra A Springer Selected Research

Opioid Analgesics (Opioids)

7/2023	Corrigendum to 'Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder' [J. Subst. Abuse Treat. vol. 142 (2022)/108852].
7/2023	Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial.
6/2023	The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV.
11/2022	Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
4/2022	Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
1/2022	Gender differences among persons entering medication treatment for opioid use disorder in the community.
1/2022	Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
1/2021	Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.
1/2021	Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS).
1/2020	Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra A Springer Research Topics

Disease

25	Opioid-Related Disorders (Opiate Addiction) 07/2023 - 01/2012
11	Substance-Related Disorders (Drug Abuse) 04/2022 - 09/2011
7	Mental Disorders (Mental Disorder) 01/2022 - 11/2005
6	HIV Infections (HIV Infection) 01/2023 - 05/2014
6	Alcoholism (Alcohol Abuse) 01/2022 - 12/2010
6	Communicable Diseases (Infectious Diseases) 08/2021 - 01/2019
4	Infections 07/2023 - 07/2014
2	Pain (Aches) 07/2023 - 01/2022
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2015 - 11/2012
2	Coinfection 07/2014 - 06/2003
1	Major Depressive Disorder (Major Depressive Disorders) 06/2023
1	COVID-19 12/2022
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2022
1	Endocarditis 08/2021
1	Reinfection 08/2021
1	Drug Overdose 01/2021
1	Opiate Overdose 01/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2020
1	Acute Pain 01/2020
1	Mood Disorders (Mood Disorder) 01/2018
1	Laboratory Infection 01/2017
1	Hepatitis C 01/2017
1	Leukopenia 06/2005
1	Hypoalbuminemia 06/2005
1	Hyperlactatemia 06/2003
1	Lactic Acidosis 06/2003

Drug/Important Bio-Agent (IBA)

20	Naltrexone (ReVia)FDA LinkGeneric 07/2023 - 07/2014
18	Opioid Analgesics (Opioids)IBA 07/2023 - 01/2012
11	Buprenorphine (Subutex)FDA LinkGeneric 07/2023 - 01/2019
8	Methadone (Dolophine)FDA LinkGeneric 07/2023 - 01/2019
3	Cocaine (Cocaine HCl)IBA 01/2021 - 10/2013
2	Illicit Drugs (Recreational Drugs)IBA 01/2020 - 11/2005
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Cytidine Triphosphate (CTP)IBA 12/2022
1	chlorotriphenylsilane (CTPS)IBA 12/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Viral RNAIBA 01/2017
1	EnzymesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 05/2014
1	Naloxone Drug Combination Buprenorphine FDA Link 01/2012
1	Biomarkers (Surrogate Marker)IBA 06/2005
1	NucleosidesIBA 06/2003
1	Reverse Transcriptase InhibitorsIBA 06/2003
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2003

Therapy/Procedure

8	Therapeutics 01/2019 - 06/2003
4	Continuity of Patient Care 12/2021 - 01/2013
2	Art Therapy 08/2021 - 01/2014
2	Injections 01/2021 - 07/2014
1	Drug Therapy (Chemotherapy) 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 11/2012
1	Secondary Prevention 09/2011
1	Retention in Care 01/2011